Study helping transgender women access HIV prevention (PrEP)
Part of Immune system & allergy, Infections clinical trials.
This study helps transgender women who are not regularly using PrEP (a daily pill to prevent HIV) get access to HIV prevention services. It uses a smartphone to take pictures and connect with support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You were assigned male at birth and identify as a woman or transgender woman
- You are not consistently taking PrEP (fewer than 4 doses per week), or are not taking it at all
- You are not allergic to PrEP or the HIV drug tenofovir
- You speak English or Spanish (even if you cannot read or write)
- You have a smartphone that can take pictures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
This study asks people who may use PrEP—an HIV prevention medicine—about their decision to start, not start, or stop PrEP. It aims to understand needs and barriers so PrEP can work better for cisgender women and transgender people who are considering it.
This study aims to reduce HIV stigma and improve PrEP use among young transgender women in Thailand. It is testing a new program to help those who are not already taking PrEP consistently.
This study is creating a decision-making tool to help transgender women choose the right PrEP (HIV prevention pill) for them. It is looking for transgender women in Denver who are HIV-negative and interested in learning more about PrEP, as well as healthcare providers who help transgender women decide about PrEP.
This study tests a new approach to help young gay and bisexual men who take PrEP medication prevent HIV but sometimes miss doses or have condomless sex. It aims to see if behavioral strategies can improve adherence to PrEP and reduce risky behaviors.
Hear when a new AIDS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.